Manipal Health Enterprises reported a strong Q1 FY27 performance with revenue of Rs 3,091 crore, a 38% jump year-on-year. The healthcare provider saw volume-led growth across its high-acuity specialties, supported by a 290 bps increase in occupancy. While integration of the Sahyadri network continues, the company remains focused on expansion, with plans to invest Rs 4,000 crore to add 3,000 beds over the next few years. Management anticipates a significant reduction in net debt-to-EBITDA ratios following upcoming IPO proceeds utilization.
Manipal Health Enterprises Q1 Revenue Rises 38% To Rs 3,091 Crore
Revenue: Rs 3,091 crore (up 38% YoY); Network EBITDA: Rs 749 crore (up 26% YoY).
Reader Takeaway: Strong volume-led growth is driving revenue, but watch for margin normalization as greenfield hospitals ramp up.
What just happened
Manipal Health Enterprises reported robust results for Q1 FY27, characterized by significant volume-led growth. Revenue reached Rs 3,091 crore, while Network EBITDA grew to Rs 749 crore. Occupancy levels improved to 65%, marking a 290 bps increase compared to the previous year. High-acuity specialties, including Cardiology, Oncology, and Neurology, saw a 45% growth in inpatient revenue.
Why this matters
The results highlight the company's ability to drive growth through volumes rather than price hikes. The integration of Sahyadri Hospitals is progressing, with that unit contributing Rs 332 crore in revenue. Management is also prioritizing a healthy balance sheet, expecting the current net debt-to-EBITDA ratio of 2.8x to drop to 0.9x in the second quarter following the deployment of IPO proceeds.
Expansion and Capex
Manipal Health continues its aggressive expansion strategy, commissioning 103 beds in Nashik and opening a 300-bed facility in Electronic City, Bangalore. The company has earmarked Rs 2,000 crore for capital expenditure in FY27 and has a long-term plan to invest Rs 4,000 crore to add 3,000 beds over the next three to four years.
Risks to watch
Investors should monitor the margin profiles of recently acquired and greenfield hospitals. While the management characterizes current margin dips as temporary, the pace at which Sahyadri Hospitals achieves operational efficiency will be a key performance indicator. Additionally, the execution of the Raipur greenfield project, slated for Q4 FY27, remains a critical milestone.
What to track next
The primary focus areas are the ongoing integration of the Sahyadri network, the deleveraging process to reach the target debt ratio, and the utilization of new bed capacity across the network.